Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis‐related ovarian cancers

The ARID1A tumour suppressor protein is a component of the SWI/SNF chromatin remodelling complex, which is mutated in approximately 20% of all human cancers. ARID1A mutational status is considered to hold prognostic significance in a range of solid malignancies, yet in endometriosis‐related ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalique, Saira, Nash, Sarah, Natrajan, Rachael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Invited Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540905/
https://www.ncbi.nlm.nih.gov/pubmed/35647895
http://dx.doi.org/10.1002/path.5973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540905/
https://www.ncbi.nlm.nih.gov/pubmed/35647895
http://dx.doi.org/10.1002/path.5973

Ejemplares similares